✦ LIBER ✦

Pharmacogenomics in the Assessment of Therapeutic Risks versus Benefits: Inside the United States Food and Drug Administration

✍ Scribed by Issam Zineh; Michael A. Pacanowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenomic Biomarker Information in

✍ Dr. Felix W. Frueh; Dr. Shashi Amur; Dr. Padmaja Mummaneni; Dr. Robert S. Epstei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Regulatory Perspectives on Pharmacogenom

✍ Phillips, K. A. 📂 Article 📅 2006 🏛 SAGE Publications 🌐 English ⚖ 149 KB

RISK VERSUS RISK: Decision-making Dilemm

✍ Daemmrich, Arthur; Krücken, Georg 📂 Article 📅 2000 🏛 Taylor and Francis Group 🌐 English ⚖ 319 KB

Regulatory science: a special update fro

✍ Kuei-Meng Wu; Joseph G. DeGeorge; Aisar Atrakchi; Estella Barry; Anita Bigger; C 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Chromium Picolinate Intake and Risk of T

✍ Paula R. Trumbo; Kathleen C. Ellwood 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Glioblastoma survival in the United Stat

✍ Johnson, Derek R.; Leeper, Heather E.; Uhm, Joon H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB